Crestline Management, L.P.
Source: SEC Form 13F · as of Mar 2026Crestline Management, L.P. holds 2 biotech & pharma companies tracked by BioSniper, totaling $89.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
2
Total value held
$89.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Denali Therapeutics Inc. (DNLI)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| DNLIDenali Therapeutics Inc. | 4,421,464 | $84.9M |
| SANASana Biotechnology, Inc. | 1,511,472 | $4.4M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.